Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 548 of 1,261

  1. US 10058593

    Methods and compositions for oral administration of proteins

    Oramed Ltd. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  2. US 10058521

    Omega-3 pentaenoic acid compositions and methods of use

    MATINAS BIOPHARMA INC. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  3. US 10059668

    LSD1 inhibitors

    Mirati Therapeutics, Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  4. US 10058554

    Sustained release small molecule drug formulation

    Indivior UK Limited · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  5. US 10058557

    Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome

    ESSENTIALIS, INC. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  6. US 10058561

    Methods and related compositions for reduction of fat and skin tightening

    The Regents of the University of California · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  7. US 10058559

    Treatment or prevention of an intestinal disease or disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  8. US 10058614

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  9. US 10058587

    Peptide composition for cancer treatment by inhibiting TRPV6 calcium channel activity

    Soricimed Biopharma Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  10. US 10059771

    Methods for treating nasal polyposis by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  11. US 10059762

    Anti-EGFR activatable antibodies

    CytomX Therapeutics, Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  12. US 10059744

    α4β7 thioether peptide dimer antagonists

    Protagonist Therapeutics, Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  13. US 10060921

    Methods of treating transthyretin (TTR) mediated amyloidosis

    Alnylam Pharmaceuticals, Inc. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  14. US 10058602

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  15. US 10059689

    Substituted heteroaryl compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  16. US 10053706

    Parental RNAi suppression of chromatin remodeling genes to control coleopteran pests

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  17. US 10053689

    Methods for increasing efficacy of lipid formulated siRNA

    ARBUTUS BIOPHARMA CORPORATION · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  18. US 10053494

    Chemically activated nanocapsid functionalized for cancer targeting

    The Regents of the University of California · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  19. US 10053503

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  20. US 10053469

    Pyridone and aza-pyridone compounds and methods of use

    GILEAD CONNECTICUT, INC. · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  21. US 10053468

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  22. US 10053456

    Cyclopropanamine compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  23. US 10052467

    Applicator for applying a fluid to a surface

    AMNEAL PHARMACEUTICALS LLC · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  24. US 10052386

    Progesterone formulations

    Compass Therapeutics LLC · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.